Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFITM8P, or interferon induced transmembrane protein 8 pseudogene, is a genomic element whose sequence resembles those of the IFITM family (IFITM1, IFITM2, IFITM3, IFITM5, IFITM10) of interferon-induced transmembrane proteins but is not translated into a functional protein in humans[2][4]. The IFITM protein family is involved in cellular antiviral responses, immune regulation, cell proliferation, and some tumor biology, but IFITM8P is considered a pseudogene and not functionally characterized or implicated as a therapeutic target in any disease or biological pathway[2][4]. There are no aliases or alternative functional names in the literature, and no evidence for a classified molecular function, drug interaction, or relevance in clinical or research diagnostics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon induced transmembrane protein 8 pseudogene (IFITM8P).